With the advent of cardiac resynchronization therapy (CRT), and the awareness of the
impairment of ventricular systolic function caused by intraventricular conduction
disorders, especially left bundle branch block, after more than 50 years of routine use,
conventional right univentricular artificial cardiac pacing, particularly in its
classical site - the apical region - is now being questioned. In fact, conventional
right univentricular pacing usually generates a large QRS (often greater than 150 ms),
with electrocardiographic pattern of left bundle branch block - more significant signs
for the diagnosis of ventricular dyssynchrony that may require CRT.[1]Some studies have shown impairment of right univentricular pacing in patients with
pacemakers compared to normal ventricular activation,[2]-[4]
which prompted the development of algorithms of minimal ventricular pacing, favoring
exclusive atrial pacing in currently available dual-chamber pacemakers, which have shown
some benefits. However, when the reestablishment of heart rate requires ventricular
pacing (in cases of AV blocks), these algorithms cannot be used. Other studies have
shown deterioration of ventricular systolic function after initiation of right
univentricular pacing.[5],[6] In
order to minimize any impairment of right univentricular pacing in cases where it is
necessary, multiple pacing sites have been tried:[7] (outflow tract, mid-septal, inferior-septal, etc.) and, although
no further evidence has been achieved, today, mid-septal pacing is the most commonly
method in conventional pacemaker implants, to the detriment of apical pacing.Special Hisian pacing presents good results[8] and has been shown to be the best site of univentricular pacing in
terms of activation synchrony. However, some problems, such as: high pacing thresholds,
low endocavitary potentials, oversensing of atrial potential, and implantation
difficulties at this site, still need to be considered for this type of ventricular
pacing to be routinely used in patients with recommendation of pacemaker.Exclusive left ventricular pacing has been proposed as an alternative to CRT in patients
with CHF requiring ventricular pacing,[9]
and did not deliver any considerable benefits in these patients. The manuscript
“Efficacy, Safety, and Performance of Left vs. Right Ventricular Pacing in Patients with
Bradyarrhythmias: A Randomized Clinical Trial”[10] is a well-designed original study that compared these two types
of pacing in patients with preserved cardiac function and recommendation for
conventional pacemaker. The findings of that study showed low success rate and safety in
the implantation of LV electrode via the coronary sinus, contradicting the initial
assumption and questioning the appropriateness of proposing left ventricular pacing via
the coronary sinus as an option for conventional endocardial right ventricular pacing in
patients with recommendation of pacemaker. These findings, however, have been impaired
by the small number of patients included and the use of a electrode for LV pacing, which
is highly associated with low-performance and complication, not reproducing much better
results in the literature for this type of procedure.[11],[12]Although it is contested, especially in patients with cardiac systolic dysfunction, where
some guidelines recommend that preference should be given to biventricular
pacing,[1] right univentricular
pacing persists and is routinely used in patients with recommendation of conventional
pacemakers who have preserved ventricular function, and there is no consensus as to the
best site of pacing. However, preference is given to the septal region.
Authors: Pugazhendhi Vijayaraman; Mina K Chung; Gopi Dandamudi; Gaurav A Upadhyay; Kousik Krishnan; George Crossley; Kristen Bova Campbell; Byron K Lee; Marwan M Refaat; Sanjeev Saksena; John D Fisher; Dhananjaya Lakkireddy Journal: J Am Coll Cardiol Date: 2018-08-21 Impact factor: 24.094
Authors: Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer Journal: Eur J Heart Fail Date: 2016-05-20 Impact factor: 15.534
Authors: Gerald C Kaye; Nicholas J Linker; Thomas H Marwick; Lucy Pollock; Laura Graham; Erika Pouliot; Jan Poloniecki; Michael Gammage Journal: Eur Heart J Date: 2014-09-04 Impact factor: 29.983
Authors: John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi Journal: N Engl J Med Date: 2005-03-07 Impact factor: 91.245
Authors: Jens C Nielsen; Lene Kristensen; Henning R Andersen; Peter T Mortensen; Ole L Pedersen; Anders K Pedersen Journal: J Am Coll Cardiol Date: 2003-08-20 Impact factor: 24.094
Authors: Bruce L Wilkoff; James R Cook; Andrew E Epstein; H Leon Greene; Alfred P Hallstrom; Henry Hsia; Steven P Kutalek; Arjun Sharma Journal: JAMA Date: 2002-12-25 Impact factor: 56.272
Authors: Cecilia Linde; William T Abraham; Michael R Gold; Martin St John Sutton; Stefano Ghio; Claude Daubert Journal: J Am Coll Cardiol Date: 2008-11-07 Impact factor: 24.094
Authors: Shaan Khurshid; Andrew E Epstein; Ralph J Verdino; David Lin; Lee R Goldberg; Francis E Marchlinski; David S Frankel Journal: Heart Rhythm Date: 2014-06-02 Impact factor: 6.343